EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors

Xueqi Wang, Jie Wang, Shuwen Zhou, Ziyao Yang, Zhiyu Duan, Yong Wang, Zheyi Dong, Jie Wu, Xiangmei Chen, Guangyan Cai

Kidney Diseases · 14.07.2026 · 12 (1) · 759-771

DOI: 10.1159/000553450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 14.07.2026. Verfasst von Xueqi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Medical Center of Chinese PLA General Hospital, Beijing, China. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are crucial in managing proteinuria in chronic kidney disease (CKD), yet individual responses vary. Whether urinary glucose excretion, a direct pharmacodynamic marker of SGLT2is, could predict proteinuria reduction efficacy remains unclear and has not been specifically investigated.

Methods

We enrolled 277 CKD patients treated with empagliflozin (10 mg/day) between July 2024 and September 2025 at a single center, stratifying them into low (

Schlagwörter

Stichwörter der Autor:innen

BiomarkerChronic kidney diseaseEfficacy predictionEmpagliflozinGlucosuriaProteinuriaSodium-glucose transporter 2 inhibitors

Autor:innen und Institutionen

  • Department of Nephrology, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Medical School of Nankai University, Tianjin, China.

Zitieren

APA

Wang, X., Wang, J., Zhou, S., Yang, Z., Duan, Z., Wang, Y., Dong, Z., Wu, J., Chen, X., & Cai, G. (2026). Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors. Kidney Diseases, 12(1), 759-771. https://doi.org/10.1159/000553450

Vancouver

Wang X, Wang J, Zhou S, Yang Z, Duan Z, Wang Y, et al. Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors. Kidney Diseases. 2026;12(1):759-771. doi:10.1159/000553450

BibTeX
@article{Wang2026,
  author = {Wang, Xueqi and Wang, Jie and Zhou, Shuwen and Yang, Ziyao and Duan, Zhiyu and Wang, Yong and Dong, Zheyi and Wu, Jie and Chen, Xiangmei and Cai, Guangyan},
  title = {Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors},
  journal = {Kidney Diseases},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {759--771},
  doi = {10.1159/000553450}
}
Kostenlos starten →